Global Neuromodulation Devices Patent Landscape Report 2024

Global Neuromodulation Devices Market Size

The global neuromodulation devices market was valued at USD 8.65 billion in 2023. It is expected to grow at a CAGR of 10.3% during the forecast period of 2024-2032 and attain a market value of USD 20.83 billion by 2032.

The market growth is driven by innovations in neuromodulation technology, improved device designs and more effective stimulation techniques. These advancements contribute to better patient outcomes and drive adoption. There is a rapidly growing number of patents on modulating brain region methodologies. These developments have impacted the patent landscape significantly.

Patent Landscape Report Coverage

The Global Neuromodulation Devices Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for neuromodulation devices include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation associated with neuromodulation devices. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within neuromodulation device technologies.

Key Inclusions

• Patent Valuation Analysis

An evaluation and competitive benchmarking of key members of unique patent families are covered in the analysis for neuromodulation device technologies. The important parameters have been taken into consideration including IP document, year of application, number of citations, time to expiry, and jurisdiction associated with neuromodulation devices.

• Analysis of Patent Applications

A comprehensive summary of several patent applications which were filed across different jurisdictions for neuromodulation devices and their relative value are covered. The analysis will cover the capital in terms of innovation and innovation type.

• Analysis of Granted Patents

Detailed analysis of the granted patents across different jurisdictions for neuromodulation devices and their relative value in the IP are covered in the final report.

Neuromodulation Devices Patent Outlook

• There is a continuous flow of new patents related to advanced neuromodulation technologies. The innovations include novel stimulation techniques enhanced targeting of specific neural pathways. Companies operating in the neuromodulation devices market are patenting unique methods of delivering neuromodulation such as closed-loop systems.

• Key players in the neuromodulation market including Medtronic, and Boston Scientific Corporation, among others are implementing robust intellectual property strategies. They focus on securing patents related to methods of use, proprietary technologies, and device improvements to maintain a competitive edge in the market.

• The application of neuromodulation is increasing for a broader range of conditions such as neuropsychiatric disorders (depression, anxiety) and cognitive disorders. Patents covering these expanding applications reflect the growing recognition of neuromodulation in several therapeutic areas. In 2023, 600+ patents were granted signifying their expanded use.

What are Neuromodulation Devices?

Neuromodulation devices are medical technologies designed to alter nerve activity by targeted stimulation of neural pathways. These devices are used to treat several neurological and psychiatric disorders by influencing nerve communication and processing information. The types of neuromodulation devices include deep brain stimulators (DBS), spinal cord stimulators (SCS), peripheral nerve stimulators (PNS), vagus nerve stimulators (VNS) among others. These devices have applications in multiple areas including neurological disorders, pain management, and mental health among others.

The market is experiencing growth due to several reasons including the rising prevalence of neurological disorders, technological advancements, expansion of indications, and growing geriatric populations among others. The global market expansion provides an opportunity for patent companies to explore innovative products in the neuromodulation devices market.

Neuromodulation Devices Industry Growth Drivers

Technological Innovations in Simulation Methods is Expected to Boost the Patent Industry Growth

The development of advanced technologies such as more precise stimulation methods, and improved electrode materials has impacted the patent activity as innovations that enhance device efficacy and safety are crucial. The incorporation of digital technologies is fostering new patent filings. In 2023, 624 patents were granted, rising from 611 in 2022. Patents covering these technologies are crucial for companies to maintain a competitive edge in the market, thus impact the neuromodulation devices patent landscape significantly.

Intellectual Property Strategies and Expansion of Clinical Applications is Expected to Propel Neuromodulation Devices Patent Industry 

The neuromodulation devices patent industry is driven by continuous technology innovation. Companies are developing comprehensive patent portfolios to protect their innovations and establish a strong market presence. This strategy involves filing patents for core technologies. Moreover, licensing agreements and strategic partnerships often involve the exchange of patented technologies. Along with the strategic initiatives, patents are increasingly being filed for expanding therapeutic areas such as neuropsychiatric disorders and neurodegenerative diseases among others. This dynamic creates opportunities for additional patent filings and exploration of new technologies.

Neuromodulation Devices Patent Segmentation

The report will cover the following sections in detail:

Analysis by Product Type

• Spinal Cord Stimulators

• Deep Brain Stimulators

• Sacral Nerve Stimulators

• Vagus Nerve Stimulators

• Transcranial Magnetic Stimulators

• Others

Analysis by Technology

• Internal

• External

Neuromodulation Devices Patent Segmentation Analysis

The breakup based on product type includes spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, transcranial magnetic stimulators, and others. Spinal cord stimulators are medical devices which are designed to manage chronic pain and some neurological conditions by delivering electrical impulses to the spinal cord.

Detailed technological data will be provided for all specified segments classified in this report.

Neuromodulation Devices Patent Jurisdiction Analysis

The United States is one of the leading jurisdictions for neuromodulation device patents, having around 11,000+ patents. The presence of key companies, well-established healthcare infrastructure, growing innovations, rising cases of neurological disorders and advanced research and development activities contribute to the regional patent landscape significantly.

Patent Profile of Key Companies

Among the players with neuromodulation devices patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the neuromodulation devices field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:

Medtronic Inc.

Medtronic Inc. was founded in 1949 and headquartered in Ireland. The company is engaged in developing, manufacturing, and distributing several medical devices including neuromodulation devices. The company is a global leader in the field of medical devices and has patents in the field of neuromodulation technologies.

Advanced Neuromodulation Systems Inc.

Advanced Neuromodulation Systems Inc. was founded in 1979 and is headquartered in the United States. The company is engaged in designing, developing, manufacturing and marketing advanced implantable neuromodulation devices.

Other companies include Cardiac Pacemakers Inc., Univ California, Boston Scient Neuromodulation Corp, Saluda Medical Pty LTD, Cyberonics Inc., Galvani Bioelectronics LTD, Mashiach Adi, Nyxoah Sa, Neuropace Inc., and Greatbatch LTD among others.

Reasons to Purchase this Report

The neuromodulation devices patent report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by - 

• Competitive Advantage: The landscape reveals the market leaders, potential partners and innovators and makes it understandable which companies have important patents in this field of neuromodulation devices.

• Innovation Insights: The patent analysis reveals new innovations and technologies in neuromodulation devices. 

• Market Positioning: Companies with strong patent portfolios gain a competitive advantage because their intellectual property assets differentiate their products. Understanding their intellectual property strategy reveals the market position of new entrants and potential barriers to entry within the neuromodulation devices patent landscape.

• Risk Assessment: In technology-intensive fields such as neuromodulation devices, risks of IP infringement are common. Analyzing patent landscapes helps companies assess risk, develop mitigation strategies, and inform licensing, partnering, and acquisition decisions.

Key Questions Answered in the Neuromodulation Devices Patent Landscape Report

• Who are the key players in the neuromodulation devices patent landscape?
• How is the patent portfolio distributed geographically?
• What are the emerging trends in neuromodulation device patents?
• How has the patent landscape evolved over time?
• What are the strategic insights for market players and investors?
• What is the technological focus of patents in the neuromodulation devices industry?
• How do patent strategies impact competitive advantage?
• What are the implications of patent filings in neuromodulation devices?
• What are the challenges and opportunities in the neuromodulation devices patent landscape?
• What are the regulatory and legal considerations?
• What technological innovations have recently emerged in neuromodulation devices?

Related Reports

Neuromodulation Devices Market

Noninvasive Neuromodulation Market

Neurodiagnostic and Monitoring Devices Market